The QMN Weekly Bulletin
May 23. 2008
| Vol.
2 No.
21
Medtronic is recalling certain heparin-coated disposable products used during cardiopulmonary bypass for heart surgeries.
While settling patent litigation last month over the blockbuster acid reflux disease treatment Nexium, AstraZeneca and Ranbaxy entered into manufacturing agreements for several drugs.
Actavis Totowa, a U.S. manufacturing division of Icelandic drugmaker Actavis, has recalled all lots of heart failure treatment Digitek as a precautionary measure.
Union Health Ministry to set up a vaccine manufacturing unit, with World Health Organisation's licence and a medical park in Chengalpattu, 30 kms away from Chennai.
Sanofi-aventis [has inaugurated] a series of expansions and upgrades to its Canadian headquarters.
The National Standards Authority of Ireland (NSAI) is investing millions of euros to help medical device companies gain faster access to the European market.
Oncolytics Biotech Inc. announced that it has successfully transferred cGMP production for Reolysin at the 40-litre batch size to SAFC Pharma, a division of Sigma-Aldrich Corporation.
Edwards Lifesciences Corporation … announced the opening of its new heart valve manufacturing facility in Changi North Crescent, Singapore.
Amid a boom in demand for surgical equipment and medical devices, ProMold Plastics, a longtime Cromwell plastics manufacturing firm, has relocated to the Portland building formerly occupied by Sweet Waverly Printing Co.
|
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews
All rights reserved. Do not duplicate or redistribute in any form.